A SIX-YEAR-OLD girl from Clevedon who almost died of a rare heart condition before having a replacement fitted, is due to compete in the British Transplant Games this week.
Sanofi's Genzyme recalls transplant drug after stability test failure – FiercePharma Manufacturing
Sanofi's Genzyme recalls transplant drug after stability test failureFiercePharma ManufacturingThe company, whose vaccine division has been battling mold problems at a plant in Canada, now is voluntarily recalling 9 lots of Thymoglobulin, used to t…
Newport man performs kidney treatment at home
As kidney disease breaks into the list of top 10 killers of Americans, those suffering from it look for ways to return a sense of normalcy to their lives. When kidneys fail, patients must begin dialysis in order to survive, a process in which excess…
Non-Hodgkin's lymphoma and chronic lymphocytic leukaemia – Pharmacy Europe
Non-Hodgkin's lymphoma and chronic lymphocytic leukaemiaPharmacy EuropeTreanda is approved in patients with chronic lymphocytic leukaemia (CLL) who have received no prior treatment and in patients with relapsed indolent B-cell non-Hodgkin's lym…
Engineering Newswire: Toilets Of The Future
In this episode of Engineering Newswire — from Product Design & Development — the toilet gets redesigned; test flight of hypersonic Waverider fails; NASA's Morfius Project crashes and burns; MIT's autonomous planes flies indoors; sunglass…
First international consensus on cardiac resynchronization therapy in heart … – MTBeurope
Minneapolis Star TribuneFirst international consensus on cardiac resynchronization therapy in heart …MTBeuropeThe European Heart Rhythm Association (EHRA) and the US Heart Rhythm Society (HRS) have jointly produced recommendations for the practical m…
Heart-failure spike after Japan earthquake – TheHeart.Org
Zee NewsHeart-failure spike after Japan earthquakeTheHeart.OrgMunich, Germany- Japanese researchers have reported a striking and prolonged increase in the occurrence of heart failure after the massive earthquake that hit there in March 2011 [1]. A sust…
Novartis' LCZ696 to benefit patients with heart failure – Express Pharma
TopNews New ZealandNovartis' LCZ696 to benefit patients with heart failureExpress PharmaNovartis came out with the results from the phase II Paramount study showing that the investigational compound LCZ696 is the first therapy to significantly redu…
Sanofi's Genzyme recalls kidney transplant rejection drug – Reuters
Sanofi's Genzyme recalls kidney transplant rejection drugReutersAug 28 (Reuters) – The U.S. health regulator said Sanofi's rare disease division, Genzyme, voluntarily recalled nine lots of its drug Thymoglobulin, which treats transplant rejecti…
Eplerenone shown to reduce cumulative heart failure hospitalisations – News-Medical.net
Eplerenone shown to reduce cumulative heart failure hospitalisationsNews-Medical.netPfizer Inc. (NYSE: PFE) announced results from a new post-hoc analysis of the EMPHASIS-HF trial showing statistically significant reductions in rates of cumulative hear…